Heron Therapeutics
HRTX
#8074
Rank
C$0.25 B
Marketcap
$1.70
Share price
-5.47%
Change (1 day)
123.34%
Change (1 year)

EPS for Heron Therapeutics (HRTX)

EPS in 2023 (TTM): -$1.58

According to Heron Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.64. In 2022 the company made an earnings per share (EPS) of -$2.42 an increase over its 2021 EPS that were of -$3.15.

EPS history for Heron Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.58-34.85%
2022-$2.42-23.11%
2021-$3.15-10%
2020-$3.50-0%
2019-$3.501.21%
2018-$3.46-32.7%
2017-$5.14-19.34%
2016-$6.3854.76%
2015-$4.121.73%
2014-$4.05-16.23%
2013-$4.8391.67%
2012-$2.52-31.45%
2011-$3.68-27.06%
2010-$5.04-43.75%
2009-$8.97-57.33%
2008-$21.02-82.92%
2007-$123.0220.61%
2006-$102.00175.76%
2005-$36.99-21.43%
2004-$47.08100%
2003-$23.54-38.24%
2002-$38.11161.54%
2001-$14.57-106.46%
2000$225.432051.55%
1999$10.48839.73%
1998$1.11-105.48%
1997-$20.36-88.16%
1996-$171.98

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$1.82-211.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$0.20-111.97%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.28 39.32%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.20-234.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.31 41.03%๐Ÿ‡บ๐Ÿ‡ธ USA